Show Summary Details
Page of

Blood products and fluid therapy 

Blood products and fluid therapy
Chapter:
Blood products and fluid therapy
Author(s):

Keith G. Allman

, Iain H. Wilson

, and Aidan O’Donnell

DOI:
10.1093/med/9780199584048.003.0038
Page of

PRINTED FROM OXFORD MEDICINE ONLINE (www.oxfordmedicine.com). © Oxford University Press, 2016. All Rights Reserved. Under the terms of the licence agreement, an individual user may print out a PDF of a single chapter of a title in Oxford Medicine Online for personal use (for details see Privacy Policy and Legal Notice).

date: 19 September 2019

Richard Telford

Blood products 1066

Blood conservation techniques 1072

Massive transfusion 1075

Jehovah's Witnesses 1076

Fluid and electrolyte therapy 1080

In 2008, 2.8 million units of blood and blood products were issued by the blood transfusion services of England, Scotland, Ireland and Wales. There has been a steady fall in the number of units of packed red cells issued since 1999 which probably reflects the adoption of restrictive blood transfusion practices by clinicians. All donated blood is tested for HIV-1, HIV-2, hepatitis B, hepatitis C, and syphilis. Cytomegalovirus (CMV) antibody-negative blood components are available for immunosuppressed patients and neonates. In the UK, white cells are routinely removed from blood components as a precaution against new variant Creutzfeldt–Jacob disease (vCJD), leaving a residual leucocyte count of <5×10...

Access to the complete content on Oxford Medicine Online requires a subscription or purchase. Public users are able to search the site and view the abstracts for each book and chapter without a subscription.

Please subscribe or login to access full text content.

If you have purchased a print title that contains an access token, please see the token for information about how to register your code.

For questions on access or troubleshooting, please check our FAQs, and if you can't find the answer there, please contact us.